Cargando…
International reference pricing of pharmaceuticals in the United States: Implications for potentially curative treatments
Recent federal drug price control proposals have included mechanisms to benchmark US prices to international prices. These international price referencing (IRP) proposals recommend that the US government develop an index based on prices paid by a group of higher-income countries and restrict US pric...
Autores principales: | Sullivan, Sean D, Sullivan, Kiera D, Dabbous, Omar, Garrison, Louis P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373031/ https://www.ncbi.nlm.nih.gov/pubmed/35471069 http://dx.doi.org/10.18553/jmcp.2022.28.5.566 |
Ejemplares similares
-
International reference pricing for prescription drugs: a landscape analysis
por: Rand, Leah Z, et al.
Publicado: (2021) -
The Promise of Specialty Pharmaceuticals: Are They Worth the Price?
por: Sullivan, Sean D.
Publicado: (2008) -
Cystic Fibrosis: Breakthrough Drugs at Break-the-Bank Prices
por: Orenstein, David M., et al.
Publicado: (2015) -
Collective pharmaceutical procurement in China may have unintended consequences in supply and pricing
por: Jiang, Shan, et al.
Publicado: (2020) -
Paying for Outcomes: Innovative Coverage and Reimbursement Schemes for Pharmaceuticals
por: Carlson, Josh, et al.
Publicado: (2009)